H. Burrichter

588 total citations
24 papers, 478 citations indexed

About

H. Burrichter is a scholar working on Immunology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, H. Burrichter has authored 24 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Pathology and Forensic Medicine and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in H. Burrichter's work include Lymphoma Diagnosis and Treatment (8 papers), Immune Cell Function and Interaction (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). H. Burrichter is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Immune Cell Function and Interaction (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). H. Burrichter collaborates with scholars based in Germany, Netherlands and France. H. Burrichter's co-authors include M. Schaadt, Volker Diehl, Christa Fonatsch, Hartmut Kirchner, W. Heit, H Stein, K. Oette, H.L. Ko, G. Pulverer and J. Beuth and has published in prestigious journals such as Blood, The Journal of Immunology and International Journal of Cancer.

In The Last Decade

H. Burrichter

24 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Burrichter Germany	11	242	188	128	101	89	24	478
Gunhild Lange Skovgaard Denmark	13	254 1.0×	238 1.3×	140 1.1×	143 1.4×	101 1.1×	14	649
Minghua Zhu China	12	219 0.9×	186 1.0×	159 1.2×	240 2.4×	46 0.5×	24	591
Lucienne Cicurel United States	9	194 0.8×	69 0.4×	223 1.7×	75 0.7×	193 2.2×	18	527
Paul Glover United States	13	95 0.4×	264 1.4×	250 2.0×	230 2.3×	18 0.2×	17	634
Morinobu Takahashi Japan	12	238 1.0×	19 0.1×	176 1.4×	42 0.4×	86 1.0×	28	466
T Murate Japan	11	86 0.4×	93 0.5×	220 1.7×	203 2.0×	8 0.1×	15	468
B B Lozzio United States	11	147 0.6×	19 0.1×	214 1.7×	84 0.8×	61 0.7×	42	491
MR Grever United States	12	242 1.0×	292 1.6×	299 2.3×	208 2.1×	21 0.2×	24	848
P. M�ller Germany	9	78 0.3×	107 0.6×	130 1.0×	77 0.8×	51 0.6×	14	354
J. C. Laurent France	10	176 0.7×	23 0.1×	189 1.5×	94 0.9×	59 0.7×	14	479

Countries citing papers authored by H. Burrichter

Since Specialization

Citations

This map shows the geographic impact of H. Burrichter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Burrichter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Burrichter more than expected).

Fields of papers citing papers by H. Burrichter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Burrichter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Burrichter. The network helps show where H. Burrichter may publish in the future.

Co-authorship network of co-authors of H. Burrichter

This figure shows the co-authorship network connecting the top 25 collaborators of H. Burrichter. A scholar is included among the top collaborators of H. Burrichter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Burrichter. H. Burrichter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pollok, M., et al.. (1993). Signalling via the TCR/CD3 Antigen Receptor Complex in Uremia Is Limited by the Receptors Number. The Nephron journals/Nephron journals. 64(3). 369–375. 31 indexed citations

Beuth, J., H.L. Ko, Hans‐Joachim Gabius, et al.. (1992). Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients. Journal of Molecular Medicine. 70(8). 658–61. 72 indexed citations

Burrichter, H., et al.. (1992). [Lymphocytograms in relation to storage time of CPDA1 whole blood concentrates].. PubMed. 30. 140–4. 1 indexed citations

Ohshima, Y., H.L. Ko, J. Beuth, et al.. (1991). Activation of Mononuclear Immune Cells in Response to Staphylococcal Lipoteichoic Acid. Zentralblatt für Bakteriologie. 275(3). 374–381. 7 indexed citations

Pollok, M., et al.. (1991). Does uremic environment down-regulate T cell activation via TCR/CD3 antigen receptor complex?. PubMed. 36(1). 15–21. 2 indexed citations

Burrichter, H., et al.. (1990). L428 cells derived from Hodgkin's disease produce E rosette-inhibiting factor. Blood. 76(4). 791–796. 3 indexed citations

Pulverer, G., J. Beuth, W. Roszkowski, et al.. (1990). Bacteria of Human Physiological Microflora Liberate Immunomodulating Peptides. Zentralblatt für Bakteriologie. 272(4). 467–476. 9 indexed citations

Burrichter, H., et al.. (1990). L428 cells derived from Hodgkin's disease produce E rosette-inhibiting factor. Blood. 76(4). 791–796. 1 indexed citations

Oette, K., et al.. (1990). [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].. PubMed. 108(4). 71–2, 75. 2 indexed citations

10.

Schaadt, M., H. Burrichter, Michael Pfreundschuh, et al.. (1989). Biology of Hodgkin Cell Lines. Recent results in cancer research. 117. 53–61. 3 indexed citations

11.

Burrichter, H., M. Schaadt, & Volker Diehl. (1989). Conclusions from Hodgkin-derived cell lines. Cancer treatment and research. 41. 29–41. 2 indexed citations

12.

Radtke, H., et al.. (1988). Inhibition of human neutrophil migration by supernatants from Hodgkin's disease‐derived cell lines. European Journal of Clinical Investigation. 18(3). 290–296. 9 indexed citations

13.

Schaadt, M., Christof von Kalle, Hans Tesch, H. Burrichter, & Volker Diehl. (1988). Immunologic, functional and moleculargenetic properties of Hodgkin-derived cell lines. 10. 108–122. 9 indexed citations

14.

Diehl, Volker, et al.. (1984). Hodgkin's disease: the remaining challenge.. PubMed. 30. 199–203. 1 indexed citations

15.

Burrichter, H., et al.. (1984). Interleukin-l-Like Activity Constitutively Generated by Hodgkin Derived Cell Lines. Immunobiology. 166(3). 318–333. 17 indexed citations

16.

Burrichter, H., W. Heit, M. Schaadt, Hartmut Kirchner, & Volker Diehl. (1983). Production of colony‐stimulating factors by Hodgkin cell lines. International Journal of Cancer. 31(3). 269–274. 40 indexed citations

17.

Kniep, Bernhard, et al.. (1983). Gangliotriaosylceramide (asialo GM2), a glycosphingolipid marker for cell lines derived from patients with Hodgkin's disease.. The Journal of Immunology. 131(3). 1591–1594. 13 indexed citations

18.

Diehl, Volker, H. Burrichter, M. Schaadt, et al.. (1983). Hodgkin’s Disease Cell Lines: Characteristics and Biological Activities. Hämatologie und Bluttransfusion. 28. 411–417. 11 indexed citations

19.

Diehl, Volker, H. Burrichter, M. Schaadt, et al.. (1983). Hodgkin's cell lines: Characteristics and possible pathogenetic implications. Hematological Oncology. 1(2). 139–147. 16 indexed citations

20.

Fonatsch, Christa, H. Burrichter, M. Schaadt, Hartmut Kirchner, & Volker Diehl. (1982). Translocation t(8;22) in peripheral lymphocytes and established lymphoid cell lines from a patient with Hodgkin's disease followed by acute lymphatic leukemia. International Journal of Cancer. 30(3). 321–327. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact